Beta-blockers and ACE inhibitors: New data, old myths

Gary S. Francis, William R Lewis, William Parmley, C. Wayne Weart

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Clinical trials have demonstrated new, safe, efficacious ways to use these cardiovascular agents: Beta-blockers are now first-line treatment for heart failure, and the HOPE trial showed that ACE inhibitors reduce morbidity and mortality in patients at high risk of cardiac events.

Original languageEnglish (US)
Pages (from-to)62-84
Number of pages23
JournalPatient Care
Volume34
Issue number13
StatePublished - 2000

Fingerprint

Cardiovascular Agents
Treatment Failure
Angiotensin-Converting Enzyme Inhibitors
Heart Failure
Clinical Trials
Morbidity
Mortality

ASJC Scopus subject areas

  • Leadership and Management

Cite this

Francis, G. S., Lewis, W. R., Parmley, W., & Weart, C. W. (2000). Beta-blockers and ACE inhibitors: New data, old myths. Patient Care, 34(13), 62-84.

Beta-blockers and ACE inhibitors : New data, old myths. / Francis, Gary S.; Lewis, William R; Parmley, William; Weart, C. Wayne.

In: Patient Care, Vol. 34, No. 13, 2000, p. 62-84.

Research output: Contribution to journalArticle

Francis, GS, Lewis, WR, Parmley, W & Weart, CW 2000, 'Beta-blockers and ACE inhibitors: New data, old myths', Patient Care, vol. 34, no. 13, pp. 62-84.
Francis GS, Lewis WR, Parmley W, Weart CW. Beta-blockers and ACE inhibitors: New data, old myths. Patient Care. 2000;34(13):62-84.
Francis, Gary S. ; Lewis, William R ; Parmley, William ; Weart, C. Wayne. / Beta-blockers and ACE inhibitors : New data, old myths. In: Patient Care. 2000 ; Vol. 34, No. 13. pp. 62-84.
@article{72271076404e4c82be1b4b91271565ce,
title = "Beta-blockers and ACE inhibitors: New data, old myths",
abstract = "Clinical trials have demonstrated new, safe, efficacious ways to use these cardiovascular agents: Beta-blockers are now first-line treatment for heart failure, and the HOPE trial showed that ACE inhibitors reduce morbidity and mortality in patients at high risk of cardiac events.",
author = "Francis, {Gary S.} and Lewis, {William R} and William Parmley and Weart, {C. Wayne}",
year = "2000",
language = "English (US)",
volume = "34",
pages = "62--84",
journal = "Patient Care",
issn = "0031-305X",
publisher = "Advanstar Communications",
number = "13",

}

TY - JOUR

T1 - Beta-blockers and ACE inhibitors

T2 - New data, old myths

AU - Francis, Gary S.

AU - Lewis, William R

AU - Parmley, William

AU - Weart, C. Wayne

PY - 2000

Y1 - 2000

N2 - Clinical trials have demonstrated new, safe, efficacious ways to use these cardiovascular agents: Beta-blockers are now first-line treatment for heart failure, and the HOPE trial showed that ACE inhibitors reduce morbidity and mortality in patients at high risk of cardiac events.

AB - Clinical trials have demonstrated new, safe, efficacious ways to use these cardiovascular agents: Beta-blockers are now first-line treatment for heart failure, and the HOPE trial showed that ACE inhibitors reduce morbidity and mortality in patients at high risk of cardiac events.

UR - http://www.scopus.com/inward/record.url?scp=0003010345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0003010345&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0003010345

VL - 34

SP - 62

EP - 84

JO - Patient Care

JF - Patient Care

SN - 0031-305X

IS - 13

ER -